AlzChem Group AG (FRA:ACT)

Market Cap	1.64B +55.9%
Revenue (ttm)	575.05M +2.1%
Net Income	63.46M +17.4%
EPS	6.28 +18.1%
Shares Out	n/a
PE Ratio	25.81
Forward PE	24.81
Dividend	2.10 (1.27%)
Ex-Dividend Date	May 6, 2026

Volume	18,752
Average Volume	163
Open	166.00
Previous Close	164.80
Day's Range	160.60 - 166.00
52-Week Range	76.20 - 178.40
Beta	n/a
RSI	49.46
Earnings Date	Apr 30, 2026

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silico...

• Industry: Chemicals and Allied Products
• Founded: 1908
• Employees: 1,680
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ACT

Financial Performance

In 2025, AlzChem Group AG's revenue was 575.05 million, an increase of 2.06% compared to the previous year's 563.44 million. Earnings were 63.46 million, an increase of 17.35%.